Objective: To determine whether the obstetric gel shortens the second stage of labor and exerts a protective effect on the perineum. Method: A total of 251 nulliparous women with singleton low-risk pregnancies in vertex position at term were recruited. A total of 228 eligible women were randomly assigned to Group A, without obstetric gel use, or to Group B, obstetric gel use, i.e., intermittent application into the birth canal during vaginal examinations, starting at the early first stage of labor (prior to 4 cm dilation) and ending with delivery. Results: A total of 183 cases were analyzed. For vaginal deliveries without interventions, such as C-section, vaginal operative procedure or Kristeller maneuver, obstetric gel use significantly shortened the second stage of labor by 26 min (30%) (Ps0.026), and significantly reduced perineal tears (Ps0.024). First stage of labor and total labor duration were also shortened, but not significantly. Results did not show a significant change in secondary outcome parameters, such as intervention rates or maternal and newborn outcomes. No side effects were observed with obstetric gel use. Conclusion: Systematic vaginal application of obstetric gel showed a significant reduction in the second stage of labor and a significant increase in perineal integrity. Future studies should further investigate the effect on 
Introduction
In the past few decades, a causal link between birth injury and postpartum pelvic floor dysfunction has been established w13x. Vaginal birth increases 4-11 times the risk of developing pelvic organ prolapse w16x, and 2.7 times the risk of stress urinary incontinence w21x. Perineal trauma in childbirth can result in urinary and fecal incontinence, painful intercourse, and persistent perineal pain w12x. Obstetric factors responsible for anal sphincter rupture and fecal incontinence have been studied and include forceps delivery, episiotomy and prolonged second stage w8, 9, 13, 18, 24x. Several other studies also documented a prolonged second stage as a risk factor for pelvic floor injury w6, 9x. Although the duration of second stage labor is not associated with impaired neonatal outcome, it is associated with increased maternal morbidity and operative delivery rates in nulliparous women w6x. In multiparous women, an association between the duration of second stage of labor and increased maternal and neonatal morbidity was found: a duration exceeding 2 h increased the risk for operative vaginal delivery, a duration exceeding 3 h increased the risk for perineal lacerations and undesirable neonatal outcomes w7x.
With the goal of optimizing labor outcomes, many techniques have been investigated: nulliparous women decreased their trauma risk by undergoing perineal massage a few weeks before delivery w10x. Evidence from randomized clinical trials (RCT) has shown that avoiding episiotomy protects the perineal integrity w5, 10x, while the upright maternal position during the second stage of labor did not affect overall perineal trauma w10x. The procedure of a perineal massage with a lubricant at late second stage had been previously investigated, and showed a reduction in the duration of the second stage without showing a significant effect on perineal integrity w3, 23x.
The ideal management of labor should maximize the probability of vaginal delivery and minimize the risk for maternal and neonatal morbidity. The aim of this randomized controlled trial was to investigate the effects of a specially designed obstetric gel, Dianatal ᮋ (MPC INTER-NATIONAL S.A., 26, Boulevard Royal, L-2449 Luxembourg), on labor outcomes, focusing on the length of the second stage of labor and on perineal integrity. In contrast to the previous investigations using ''classical perineal massage'' with a lubricant in the late second stage of labor w3, 23x, the goal of this investigation was to optimize the lubrication effect on vaginal delivery not only by using a specially developed obstetric gel containing polyacrylic acid as a bioadhesive agent, but also by starting intermittent intravaginal application during the first stage of labor. Both institutions are recognized educational institutions. In both institutions similar routine care was used: delivery was attended by a midwife and a doctor, the vaginal exams and application of gel were usually done by midwives, and episiotomy was used selectively.
Materials and methods
The study was performed as a randomized, controlled, multicenter parallel group trial in nulliparous women (computer randomization with use of envelopes). Due to the type of procedure, it was impossible to carry out a blinded or placebo controlled study.
Patients were randomly assigned to either Group A (standard of care in accordance with the established guidelines of the department without obstetric gel use) or to Group B (standard of care in accordance with the established guidelines of the department, plus vaginal application of the obstetric gel according to the study protocol). For the analysis of outcome parameters, Groups A and B have been further divided into the following subgroups in order to eliminate intentional influences on labor durations: Verbal and written consent was obtained in German by the clinical midwife. The patient record was marked indicating consent, refusal or ineligibility for the study. At hospital admission for delivery, the eligible women were checked to see if they fulfilled the inclusion criteria. If so, they were then asked if they still wished to participate in this study.
This study was carried out in accordance with the recommendations of the Declaration of Helsinki, adopted by the 18 th WMA General Assembly Helsinki, Finland, June 1964, and lastly amended by the 52 nd WMA General Assembly, Edinburgh, Scotland, October 2000.
Inclusion and exclusion criteria
The following were defined as inclusion criteria: age between 18 and 40 years; signed written informed consent; intended vaginal delivery; nulliparous state; singleton baby in vertex presentation (finally evaluated post partum); estimated birth weight between 2000 g and 4500 g (clinically or by sonography); and low risk pregnancy at term (37-42 weeks' gestation). The following were defined as exclusion criteria: contraindications for vaginal delivery; indications for an amniotic infection; indications of fetal distress; prolonged rupture of the membranes ()24 h); suspected fetal malformations; indications of cephalopelvic disproportion; severe concomitant maternal disease; women performing water births.
Study outcome parameters
The following primary outcome parameter was assessed: reduction in the length of the second stage of labor (full dilation of the cervix until birth of the newborn). The secondary outcome parameters were reduction in the length of the first stage of labor (cervical dilation between 4 cm and 10 cm); reduction of perineal lacerations; differences in newborn outcomes (Apgar score 1, 5 and 10 min after birth; umbilical cord pH); differences in obstetric interventions (cesarean section, vaginal operative interventions, episiotomies). Likewise, maternal and newborn side effects due to the obstetric gel were also investigated.
Obstetric gel specifications
A specially-designed sterile obstetric gel was used for this investigation. The obstetric gel is based on cross-linked polyacrylic acid, hydroxyethylcellulose and propylene glycol, and is free of preservatives. A steam vaporization process was used for sterilization. Farco Pharma GmbH Kö ln/Klosterfrau Berlin GmbH, Germany, manufactured the product in accordance with GMP (good manufacturing practice) regulations. Prior to this study, extensive biocompatibility studies were performed at Toxikon Europe, Leuven, Belgium, according to FDA (food and drug administration) standards. These studies showed a safe biocompatibility profile with no indications for maternal or newborn hazards. The obstetric gel received the CE (Communauté Europé enne) Trade Mark during the course of the study (Medical Device Type I, December 2005). The obstetric gel has the following special properties that are mandatory for use in obstetrics: high mucoadhesive activity; high viscosity; electric conductivity; sterile; and non-allergenic. The special properties should also guarantee its safe use in the obstetric environment, with the potential unforeseeable need to switch over to cesarean section and/or perform electrosurgery.
The obstetric gel was supplied by HCB (happy child birth) Happy Child Birth Holding and Foundation in sterile single-use, packed 11 mL syringes, and stored at room temperature.
Gel application method
In study Group B, the obstetric gel was intermittently applied into the birth canal during vaginal examination, beginning with the first vaginal examination. The gel administration started in the early first stage of labor (prior to 4 cm cervical dilation) and ended with the delivery of the newborn. 3-5 mL of gel were evenly distributed in the vagina at each examination using a sterile glove (maximal duration: 30 s). The administration of the gel was generally instructed, but not specially trained. The gel was applied manually into the birth canal without a vaginal applicator. No perineal massage was performed. After delivery of the newborn's head, the mouth-nose region was cleaned with a dry towel.
Data management
Data management was carried out under the supervision of the Division of Clinical Pharmacology and Toxicology, University Clinic of Basel, Switzerland. Randomization, design and preparation of the case report forms were carried out by Analytical International GmbH, Lö rrach, Germany. Data entry was performed in duplicate by two different people. During entry, data were checked for completeness and plausibility. If the two data sets showed discordant values, entries were again checked against the raw data and consolidated.
Statistical analysis
The durations of the first and second stages of labor were compared between the study groups by analysis of variance (ANOVA), with age, body mass index, birth weight of neonate, and center as covariates. Comparisons were performed using SPSS for Windows software wVersion 11.0 (Chicago, USA)x. The level of significance was set at Ps0.05. For odds ratio calculations in perineal lacerations, the software Graph Pad Instat Version 3.06 (GraphPad Software Inc., San Diego, USA) was also used.
Secondary outcome parameters were compared between the groups by analysis of variance (continuous variables), nonparametric Mann-Whitney U-test (scores) and x 2 -test or Fisher's exact test, as appropriate.
All parameters have been analyzed descriptively: raw data have been tabulated by treatment, and graphical representations have been made.
Power analysis with regard to sample size
The primary outcome parameter was defined as the reduction in the length of the second stage of labor. The expected effect was a 50% reduction in the difference of labor duration between nulliparous and multiparous women. In the following, recentlyestablished and widely-accepted labor duration times are given w2x:
Overall ethnical groups length of labor times are:
• In order to ensure an 80% power of detecting a difference in means of 18 min (the difference between a Group 1 mean of 53 min and a Group 2 mean of 35 min), a sample size of 87 in each group was estimated, assuming that the common standard deviation is 42 min (corresponding to 80%) using a two group t-test with a 0.05 two-sided significance level (calculated by nQuery Advisor 5.0) (Statistical Solutions, Saugus, USA). To account for drop-outs, ns100 for both treatment groups was chosen.
Results
A total of 251 women were recruited in both study centers; 228 proved eligible for study participation, and were randomly assigned to the two study groups. From this group, women deciding for a waterbirth were excluded from the analysis, and the resulting 183 cases were analyzed (Table 1) . Of these, 89 cases were treated according to the established standards of care of the study centers and were assigned to Group A, and 94 cases were treated with the obstetric gel according to the application instructions, and in accordance with the established standards of care, and were assigned to Group B. There was no statistically significant difference in the proportion of treatment groups per center. There was no statistically significant difference in the demographic and outcome parameters of the mothers and neonates between the study groups (Table 2) . Study groups did not differ significantly in the prevalence of occipito-anterior, occipito-posterior or deflexion position. Likewise, there was no statistically significant difference in the number of cesarean sections, vacuum and forceps extractions, Kristeller maneuvers, elective amniotomy or epidural anesthesia between the study groups.
To evaluate the impact of the obstetric gel use on labor facilitation, our focus was set on the subgroup analysis Ps0.024). Values after 10 min did not differ significantly. Arterial and venous umbilical pH values were likewise comparable and did not differ in a statistically significant manner between the study groups. Intervention rates, such as Kristeller maneuver, amniotomy or epidural anesthesia, did not differ significantly between the study groups. As shown in Table 5 , the prevalence of episiotomy did not differ significantly between Group A-I and B-I (A-I and B-I): Episiotomy was performed in eight patients in Group A-I and in nine patients in the Group B-I. An intact perineum was observed in nine patients in Group A-I and in 14 patients in Group B-I. This difference was not significant, but showed a tendency (Ps0.072, Table 5 ).
To further assess perineal outcome dependent on the obstetric gel use, women with Kristeller maneuver were also included into the analysis, and with their admission, Groups A-II and Group B-II were formed. As an indicator of perineal protection, intact perineum rates were compared with perineal lacerations. Episiotomies were not referenced. Comparing Group A-II with Group B-II the rate of intact perineum increased by 15% with the obstetric gel use. This difference was statistically significant (Ps0.024, Table 5 ).
The grades of the perineal lacerations did not differ significantly among the study groups: In Group A-II the mean perineal lesion grades were 1.66"0.48 (median 2) compared to 1.62"0.71 (median 1.5) in Group B-II. In the group with obstetric gel use, the highest laceration reported was grade 3 (twice), whereas in the group without gel, the highest reported laceration grade was grade 2. There was no significant difference in the prevalence of EDA (epidural anesthesia) between the study groups A-II and B-II (data not shown).
Average gel use in Group B was 24.3"1.2 (SEM) mL. The amount of obstetric gel use did not depend on interventions, such as vacuum extraction, forceps extraction, Kristeller, EDA (epidural anesthesia) or amniotomy.
Until the time of discharge from the hospital, possible maternal or neonatal side effects caused by the obstetric gel were assessed by the midwives and by the physicians. The follow-up spans an average of three postnatal days. Among the 94 cases in Group B, neither the midwives nor the obstetricians reported adverse events or side effects potentially associated with the use of the obstetric gel. The use of the obstetric gel did not nega-tively influence vaginal operative procedures. No negative influence was seen by switching to cesarean section or by the use of electrosurgery.
Discussion
Friction force has been widely identified as an important opposing force to vaginal childbirth w4, 11, 14, 15, 17, 19, 20, 22x , being influenced by parity and being modified by reducing the friction coefficient by a lubricant. The ancient Greek, Chiron, promoted the use of olive oil and water to facilitate the delivery of a horse in the 4 th century BC, a procedure established today as a gold standard in veterinary medicine w1x. To the best of our knowledge, this is the first randomized controlled trial that evaluates the effects of a specially-formulated obstetric gel, used in accordance with the veterinary procedure with labor facilitation and perineal protection.
In women undergoing vaginal delivery without interventions, such as C-sections, vaginal operative procedures or Kristeller maneuver, the use of the obstetric gel did shorten the second stage of labor by 30% (26 min), in a statistically significant and clinically meaningful manner (Ps0.026). The EDA rates did not differ significantly between the study groups. Labor stage I and total labor duration were not significantly reduced. Our results showing a significantly shortened second stage of labor are supported by the group of Stamp et al. who also demonstrated, to a lesser extent, a significant reduction in the second stage of labor by 11 min through perineal massage w23x.
Our results did not show a significant change in secondary outcome parameters, such as intervention rates and maternal and neonatal outcomes. However, in women undergoing vaginal deliveries without interventions, Apgar values after 1 and 5 min were significantly lower in the group with obstetric gel use. Although significant, these differences were not clinically meaningful and can be explained by the obstetric gel influencing the visual and tactile appearance of the newborn, important components of the Apgar score.
In women experiencing vaginal deliveries without interventions, such as cesarean section or vaginal operative procedure, the use of the obstetric gel showed a statistically significant increase in the perineal integrity (Ps0.024). This finding has not yet been reported by other authors. Neither Stamp et al. w23x nor Albers et al. w3x could demonstrate such an effect in their randomized trials. This newly demonstrated effect of perineum protection can be attributed either to the special properties of the obstetric gel, or to the different application procedure starting at early first stage of labor in this trial. Stamp et al. and Albers et al. did investigate the effect of perineal massage on late second stage of labor with an ordinary lubricant used for vaginal examinations (K-Y Gel ᮋ ), Johnson and Johnson (New Brunswick, USA). In contrast to this gel, the polyacrylic acid component of the obstetric gel used in this study is known to have one of the highest mucoadhesive properities, and is able to induce a mucoadhesive film onto the birth canal that eventually leads to the newly seen perineal protecting effect. This effect may be further supported by the different application procedure used in this trial which started at early first stage of labor, compared to the perineum massage investigated by Stamp and Albers and their respective coworkers.
In this trial, no adverse events or side effects potentially linked with the use of the obstetric gel, such as allergic reactions, infections, or newborn aspiration, have been reported by the midwives or physicians. These findings suggest that the use of the obstetric gel for labor facilitation starting at early first stage of labor can be regarded as safe in humans.
The systematic use of the obstetric gel in vaginal childbirth did show significant effects in shortening the second stage of labor and in perineal protection. To further investigate the impact of the obstetric gel on secondary outcome parameters, such as intervention rates and maternal and neonatal outcomes, larger clinical trials will have to be carried out.
